Lord, Abbett & Co’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q2 | – | Sell |
-27,286
| Closed | -$3.96M | – | 705 |
|
2020
Q1 | $3.96M | Sell |
27,286
-3,754
| -12% | -$545K | 0.02% | 563 |
|
2019
Q4 | $5.3M | Sell |
31,040
-2,378
| -7% | -$406K | 0.02% | 593 |
|
2019
Q3 | $5.95M | Buy |
33,418
+5,549
| +20% | +$987K | 0.02% | 615 |
|
2019
Q2 | $7.26M | Buy |
27,869
+11,317
| +68% | +$2.95M | 0.02% | 614 |
|
2019
Q1 | $4.73M | Buy |
16,552
+412
| +3% | +$118K | 0.02% | 654 |
|
2018
Q4 | $5.25M | Buy |
16,140
+1,581
| +11% | +$514K | 0.02% | 644 |
|
2018
Q3 | $6.55M | Sell |
14,559
-7,250
| -33% | -$3.26M | 0.02% | 693 |
|
2018
Q2 | $8.92M | Sell |
21,809
-27,592
| -56% | -$11.3M | 0.03% | 646 |
|
2018
Q1 | $14.4M | Buy |
49,401
+36,432
| +281% | +$10.6M | 0.04% | 547 |
|
2017
Q4 | $2.43M | Sell |
12,969
-46,230
| -78% | -$8.67M | 0.01% | 829 |
|
2017
Q3 | $9.98M | Sell |
59,199
-1,683
| -3% | -$284K | 0.03% | 635 |
|
2017
Q2 | $8.72M | Buy |
60,882
+44,967
| +283% | +$6.44M | 0.03% | 659 |
|
2017
Q1 | $1.99M | Sell |
15,915
-178,735
| -92% | -$22.4M | 0.01% | 837 |
|
2016
Q4 | $21.9M | Sell |
194,650
-666,607
| -77% | -$75.1M | 0.07% | 397 |
|
2016
Q3 | $111M | Buy |
861,257
+31,916
| +4% | +$4.1M | 0.34% | 60 |
|
2016
Q2 | $90.6M | Buy |
829,341
+148,400
| +22% | +$16.2M | 0.28% | 79 |
|
2016
Q1 | $64.6M | Buy |
680,941
+256,394
| +60% | +$24.3M | 0.2% | 150 |
|
2015
Q4 | $38.3M | Sell |
424,547
-262,893
| -38% | -$23.7M | 0.12% | 275 |
|
2015
Q3 | $63.8M | Sell |
687,440
-109,540
| -14% | -$10.2M | 0.19% | 152 |
|
2015
Q2 | $52.4M | Sell |
796,980
-434,077
| -35% | -$28.5M | 0.14% | 235 |
|
2015
Q1 | $88.1M | Buy |
1,231,057
+418,377
| +51% | +$29.9M | 0.22% | 117 |
|
2014
Q4 | $30.9M | Buy |
+812,680
| New | +$30.9M | 0.08% | 360 |
|